Panacea Biotec reports standalone net loss of Rs 47.99 crore in the June 2017 quarter

Capital Market 

Sales decline 15.68% to Rs 104.27 crore

Net Loss of reported to Rs 47.99 crore in the quarter ended June 2017 as against net loss of Rs 20.49 crore during the previous quarter ended June 2016. Sales declined 15.68% to Rs 104.27 crore in the quarter ended June 2017 as against Rs 123.66 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales104.27123.66 -16 OPM %-6.957.97 -PBDT-31.93-4.10 -679 PBT-46.32-20.82 -122 NP-47.99-20.49 -134

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, September 14 2017. 09:59 IST